Data Bridge Market Research analyses that the global depression screening market was valued at USD 10,624.91 million in 2022 and is further estimated to reach USD 15,829.87 million by 2030, and is expected to grow at a CAGR of 5.11% during the forecast period of 2023 to 2030. 

Introduction

The Depression Screening Market has gained significant attention in recent years as mental health issues become a critical focus in healthcare systems worldwide. Depression is one of the most common mental health disorders, affecting millions of individuals across all age groups. It is a leading cause of disability, often associated with other chronic illnesses, and contributes to substantial economic and social burdens. Effective screening is a vital step in early identification, timely intervention, and prevention of severe complications associated with depression.

Growing awareness of mental health, coupled with supportive policies and technological innovations, is driving demand for depression screening solutions. From digital tools and mobile health applications to advanced diagnostic assessments used in clinical settings, the market is evolving rapidly to meet the needs of diverse populations. This article explores the current landscape, drivers, challenges, regional insights, innovations, and the future outlook of the depression screening market.